Lorenz K - Search Results

1

Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium.

Machens A, Lorenz K, Sekulla C, Höppner W, Frank-Raue K, Raue F, Dralle H. Machens A, et al. Among authors: lorenz k. Eur J Endocrinol. 2013 Feb 15;168(3):307-14. doi: 10.1530/EJE-12-0919. Print 2013 Mar. Eur J Endocrinol. 2013. PMID: 23211574

2

Importance of early screening and prophylactic thyroidectomy in asymptomatic nonindex RET germline carriers.

Ukkat J, Lorenz K, Hinze R, Thomusch O, Dralle H. Ukkat J, et al. Among authors: lorenz k. World J Surg. 2001 Jun;25(6):713-7. doi: 10.1007/s00268-001-0020-9. World J Surg. 2001. PMID: 11376404

3

Medullary thyroid carcinoma.

Brauckhoff M, Lorenz K, Ukkat J, Brauckhoff K, Gimm O, Dralle H. Brauckhoff M, et al. Among authors: lorenz k. Scand J Surg. 2004;93(4):249-60. doi: 10.1177/145749690409300402. Scand J Surg. 2004. PMID: 15658665 Review.

4

Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma.

Lorenz K, Brauckhoff M, Behrmann C, Sekulla C, Ukkat J, Brauckhoff K, Gimm O, Dralle H. Lorenz K, et al. Surgery. 2005 Dec;138(6):986-93; discussion 993. doi: 10.1016/j.surg.2005.09.020. Surgery. 2005. PMID: 16360382 Clinical Trial.

5

[Hereditary thyroid cancer].

Dralle H, Machens A, Lorenz K. Dralle H, et al. Among authors: lorenz k. Chirurg. 2008 Nov;79(11):1017-28. doi: 10.1007/s00104-008-1558-y. Chirurg. 2008. PMID: 18818894 Review. German.

6

Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis.

Brauckhoff M, Machens A, Hess S, Lorenz K, Gimm O, Brauckhoff K, Sekulla C, Dralle H. Brauckhoff M, et al. Among authors: lorenz k. Surgery. 2008 Dec;144(6):1044-50; discussion 1050-3. doi: 10.1016/j.surg.2008.08.028. Surgery. 2008. PMID: 19041016

7

Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities.

Machens A, Lorenz K, Dralle H. Machens A, et al. Among authors: lorenz k. J Intern Med. 2009 Jul;266(1):114-25. doi: 10.1111/j.1365-2796.2009.02113.x. J Intern Med. 2009. PMID: 19522830 Review.

8

Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.

Machens A, Lorenz K, Dralle H. Machens A, et al. Among authors: lorenz k. Ann Surg. 2009 Aug;250(2):305-10. doi: 10.1097/SLA.0b013e3181ae333f. Ann Surg. 2009. PMID: 19638924

9

Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma.

Trojanowicz B, Sekulla C, Lorenz K, Köhrle J, Finke R, Dralle H, Hoang-Vu C. Trojanowicz B, et al. Among authors: lorenz k. Mol Cell Endocrinol. 2010 Aug 30;325(1-2):110-7. doi: 10.1016/j.mce.2010.05.022. Epub 2010 Jun 9. Mol Cell Endocrinol. 2010. PMID: 20538039

10

Papillary thyroid cancer in children and adolescents does not differ in growth pattern and metastatic behavior.

Machens A, Lorenz K, Nguyen Thanh P, Brauckhoff M, Dralle H. Machens A, et al. Among authors: lorenz k. J Pediatr. 2010 Oct;157(4):648-52. doi: 10.1016/j.jpeds.2010.04.026. Epub 2010 Jun 2. J Pediatr. 2010. PMID: 20553841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results